TABLE 1.
Drugs shown to influence renal development
| Drug | Effect of Maternal Treatment During Pregnancy on Fetal Kidney Development | Effect of Maternal Treatment While Breastfeeding on Neonatal Kidney Development |
|---|---|---|
| Aminoglycosides | Tubular alterations, low nephron count | Tubular damage, low nephron count |
| Cyclosporin A Prostaglandin synthetase inhibitors | Low nephron count, tubular alterations | Glomerular and tubular injury |
| ACE Inhibitors (ACEIs) Angiotensin Receptor Blocker (ARB) | Renal insufficiency | Atrophy of renal papilla, tubular alterations, low nephron count |
| Dexamethasone | Altered tubular transporters, low nephron count | No effect |
| Furosemide | Renal concentrating defect | No effect |
| Anti-epileptic drugs | Increased likelihood of congenital malformations (MCDK)* | No effect |
| Mycophenolate Mofetil | Renal agenesis, ectopia | No effect |
| Adriamycin | Bladder agenesis, hydronephrosis | No effect |
| Cyclophosphamide | Hydronephrosis | No effect |
Note. This table has been adapted from Schreuder, 2011.6